Human Microbiome Based Drugs and Diagnostics Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: HB7CD3C0E98EEN
Market Monitor Global

Abstracts

The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.

This report contains market size and forecasts of Human Microbiome Based Drugs and Diagnostics in Global, including the following market information:

Global Human Microbiome Based Drugs and Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Human Microbiome Based Drugs and Diagnostics market was valued at 851.9 million in 2021 and is projected to reach US$ 1647 million by 2028, at a CAGR of 9.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Microbiome Based Drugs and Diagnostics include Second Genome, Enterome Bioscience, Yakult, Dowdupont, Vedanta BioSciences, Metabiomics Corporation, ViThera Pharmaceuticals, MicroBiome Therapeutics and Osel and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Microbiome Based Drugs and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Microbiome Based Drugs and Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Human Microbiome Based Drugs and Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Therapeutics
• Diagnostics

Global Human Microbiome Based Drugs and Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Human Microbiome Based Drugs and Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Clinical Research Institutes
• Hospital
• Surgical Centers
• Others

Global Human Microbiome Based Drugs and Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Human Microbiome Based Drugs and Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Microbiome Based Drugs and Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Human Microbiome Based Drugs and Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Second Genome
• Enterome Bioscience
• Yakult
• Dowdupont
• Vedanta BioSciences
• Metabiomics Corporation
• ViThera Pharmaceuticals
• MicroBiome Therapeutics
• Osel
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Human Microbiome Based Drugs and Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Human Microbiome Based Drugs and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Human Microbiome Based Drugs and Diagnostics Market Size: 2021 VS 2028
2.2 Global Human Microbiome Based Drugs and Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Human Microbiome Based Drugs and Diagnostics Players in Global Market
3.2 Top Global Human Microbiome Based Drugs and Diagnostics Companies Ranked by Revenue
3.3 Global Human Microbiome Based Drugs and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Human Microbiome Based Drugs and Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Human Microbiome Based Drugs and Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Microbiome Based Drugs and Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Human Microbiome Based Drugs and Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Human Microbiome Based Drugs and Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Human Microbiome Based Drugs and Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Therapeutics
  4.1.3 Diagnostics
4.2 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Human Microbiome Based Drugs and Diagnostics Market Size, 2021 & 2028
  5.1.2 Clinical Research Institutes
  5.1.3 Hospital
  5.1.4 Surgical Centers
  5.1.5 Others
5.2 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Human Microbiome Based Drugs and Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Human Microbiome Based Drugs and Diagnostics Revenue, 2017-2028
  6.3.2 US Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.3.3 Canada Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Human Microbiome Based Drugs and Diagnostics Revenue, 2017-2028
  6.4.2 Germany Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.4.3 France Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.4.5 Italy Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.4.6 Russia Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Human Microbiome Based Drugs and Diagnostics Revenue, 2017-2028
  6.5.2 China Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.5.3 Japan Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.5.6 India Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Human Microbiome Based Drugs and Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Human Microbiome Based Drugs and Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.7.3 Israel Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028
  6.7.5 UAE Human Microbiome Based Drugs and Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Second Genome
  7.1.1 Second Genome Corporate Summary
  7.1.2 Second Genome Business Overview
  7.1.3 Second Genome Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.1.4 Second Genome Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 Second Genome Key News
7.2 Enterome Bioscience
  7.2.1 Enterome Bioscience Corporate Summary
  7.2.2 Enterome Bioscience Business Overview
  7.2.3 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.2.4 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Enterome Bioscience Key News
7.3 Yakult
  7.3.1 Yakult Corporate Summary
  7.3.2 Yakult Business Overview
  7.3.3 Yakult Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.3.4 Yakult Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 Yakult Key News
7.4 Dowdupont
  7.4.1 Dowdupont Corporate Summary
  7.4.2 Dowdupont Business Overview
  7.4.3 Dowdupont Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.4.4 Dowdupont Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Dowdupont Key News
7.5 Vedanta BioSciences
  7.5.1 Vedanta BioSciences Corporate Summary
  7.5.2 Vedanta BioSciences Business Overview
  7.5.3 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.5.4 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Vedanta BioSciences Key News
7.6 Metabiomics Corporation
  7.6.1 Metabiomics Corporation Corporate Summary
  7.6.2 Metabiomics Corporation Business Overview
  7.6.3 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.6.4 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 Metabiomics Corporation Key News
7.7 ViThera Pharmaceuticals
  7.7.1 ViThera Pharmaceuticals Corporate Summary
  7.7.2 ViThera Pharmaceuticals Business Overview
  7.7.3 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.7.4 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 ViThera Pharmaceuticals Key News
7.8 MicroBiome Therapeutics
  7.8.1 MicroBiome Therapeutics Corporate Summary
  7.8.2 MicroBiome Therapeutics Business Overview
  7.8.3 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.8.4 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 MicroBiome Therapeutics Key News
7.9 Osel
  7.9.1 Osel Corporate Summary
  7.9.2 Osel Business Overview
  7.9.3 Osel Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.9.4 Osel Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.9.5 Osel Key News
7.10 Merck
  7.10.1 Merck Corporate Summary
  7.10.2 Merck Business Overview
  7.10.3 Merck Human Microbiome Based Drugs and Diagnostics Major Product Offerings
  7.10.4 Merck Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2017-2022)
  7.10.5 Merck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Human Microbiome Based Drugs and Diagnostics Market Opportunities & Trends in Global Market
Table 2. Human Microbiome Based Drugs and Diagnostics Market Drivers in Global Market
Table 3. Human Microbiome Based Drugs and Diagnostics Market Restraints in Global Market
Table 4. Key Players of Human Microbiome Based Drugs and Diagnostics in Global Market
Table 5. Top Human Microbiome Based Drugs and Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Human Microbiome Based Drugs and Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Human Microbiome Based Drugs and Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Human Microbiome Based Drugs and Diagnostics Product Type
Table 9. List of Global Tier 1 Human Microbiome Based Drugs and Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Microbiome Based Drugs and Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Human Microbiome Based Drugs and Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Human Microbiome Based Drugs and Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Human Microbiome Based Drugs and Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Human Microbiome Based Drugs and Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Second Genome Corporate Summary
Table 31. Second Genome Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 32. Second Genome Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Enterome Bioscience Corporate Summary
Table 34. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 35. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Yakult Corporate Summary
Table 37. Yakult Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 38. Yakult Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Dowdupont Corporate Summary
Table 40. Dowdupont Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 41. Dowdupont Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Vedanta BioSciences Corporate Summary
Table 43. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 44. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Metabiomics Corporation Corporate Summary
Table 46. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 47. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. ViThera Pharmaceuticals Corporate Summary
Table 49. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 50. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. MicroBiome Therapeutics Corporate Summary
Table 52. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 53. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Osel Corporate Summary
Table 55. Osel Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 56. Osel Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Merck Corporate Summary
Table 58. Merck Human Microbiome Based Drugs and Diagnostics Product Offerings
Table 59. Merck Human Microbiome Based Drugs and Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Human Microbiome Based Drugs and Diagnostics Segment by Type in 2021
Figure 2. Human Microbiome Based Drugs and Diagnostics Segment by Application in 2021
Figure 3. Global Human Microbiome Based Drugs and Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Microbiome Based Drugs and Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Microbiome Based Drugs and Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Microbiome Based Drugs and Diagnostics Revenue in 2021
Figure 8. By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Human Microbiome Based Drugs and Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Second Genome Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Yakult Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dowdupont Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Osel Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck Human Microbiome Based Drugs and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)